Gene Query: OTULIN

Dataset Description Geneva Score
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 42.47
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 42.47
RNA sequencing of matched nephrectomy samples [RNA-seq] 32.19
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 32.19
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 29.04
MeRIP-seq for heat shock in B-cell lymphoma cells 27.02
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 24.27
Transcriptional profiles of normal human mature B cells 22.91
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 21.86
4sU-seq of HFF exposed to salt and heat stress 18.97
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 18.09
Primary Human B-cell Temporal Response to CD40L Stimulation 17.22
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 15.84
4sUDRB-seq: measuring transcription elongation and initiation genomewide 14.73
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 14.56
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 14.23
Role for citron kinase in prostate cancer growth 14.18
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 13.34
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 13.34
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 12.82
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 12.39
Determination of tRNA aminoacylation levels by high throughput sequencing 12.05
Effect of Hotair overexpression in human breast cancer cell lines 12.03
AR-independent prostate cancer is sustained through FGF signaling 11.76
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 11.43
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 11.43
High-throughput sequencing of PROMPT-enriched samples. 11.33
Seletive inhibition of CDK9 in DLBCL cell lines 11.27
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 11.13
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 11.13
TGF-β regulation of miRNA expression in pancreatic cancer 11.07
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 11.05
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 11.05
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 10.92
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 10.92
Intrahepatic MAIT cell gene expression revealed by RNA-seq 10.91
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 10.86
Transcriptome analysis of U87 cells upon LINC00152 knockdown 10.8
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 10.78
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 10.55
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 10.55
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 10.45
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 10.17
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 10.13
Effect of drugs on transcriptomic profiles 10.1
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 9.56
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 9.44
Impact of dieldrin on transcription in Jurkat T cells 8.92
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 8.86
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 8.84
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 8.83
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 8.71
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 8.63
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 8.44
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 8.43
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 8.43
Global response to chemotherapy-induced apoptosis 8.31
Gene expression changes caused by KRAS in MCF-10A 8.29
Short and Long RNA sequencing of human mature erythrocytes 8.27
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 8.26
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 8.21
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 8.17
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 8.08
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 8.08
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 8.08
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 7.99
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 7.98
Paxillin regulates genomic networks in prostate cancer [C4-2] 7.98
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 7.96
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 7.92
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 7.75
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 7.74
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 7.74
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 2h] 7.64
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 7.49
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 7.47
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 7.42
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 7.4
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 7.38
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 7.37
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 7.3
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 7.28
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 7.28
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 7.27
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 7.26
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 7.23
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 7.09
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 7.09
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 7.09
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 7.06
Altering cancer transcriptomes using epigenomic inhibitors 7.06
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 7.04
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 7.02
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 6.99
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 6.95
Mitochondrial dsRNA triggers antiviral signalling in humans 6.88
RNAseq analysis of ESRP regulated splicing events in prostate cancer 6.84
IDH3a KO RNA-seq 6.83
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 6.67
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 6.65
MYC dependent mRNA translation shapes gene expression and cell biology 6.64
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 6.6
hTERT promotes cell adhesion and migration independent of telomerase activity 6.57
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 6.52
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 6.5
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 6.5
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 6.48
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 6.46
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 6.35
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 6.35
Tracing Enhancer Networks using Epigenetic Traits (TENET) 6.32
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 6.31
Genetic-to-epigenetic Therapy for Pancreatic Cancer 6.29
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 6.29
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 6.23
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 6.2
The evolution of N6-methyladenosine in primates 6.04
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 6.04
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 5.98
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 5.98
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 5.93
Ribosomal footprinting of CN34-Parental and CN34-LM1a 5.92
Be1 and Be2 B cells are transcriptionally distinct 5.88
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 5.88
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 5.84
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 5.79
RNA sequencing of mechanically strained NHEKs and control NHEKs 5.77
The bromodomain protein BRD4 regulates splicing during heat shock 5.75
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 5.75
Human HAP1 cells before and after nutrient deprivation 5.75
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 5.73
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 5.7
Ribosomal footprinting of MDA-Parental and MDA-LM2 5.67
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 5.67
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 5.67
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 5.62
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 5.59
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 5.51
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 5.51
Lysine benzoylation is a novel histone mark [RNA-seq] 5.5
Lysine benzoylation is a novel histone mark 5.5
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 5.5
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 5.5
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 5.48
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 5.48
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 5.46
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 5.46
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 5.43
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 5.39
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 5.36
MYCL and EP400 are required for Max and MCPyV mediated gene activation 5.34
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 5.32
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 5.3
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 5.29
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 5.29
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 5.29
HNF1 regulates critical functions of the human epididymis epithelium. 5.29
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 5.19
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 5.19
Global gene expression profile of dasatinib-resistant RCH-ACV cells 5.19
Effect of PRDM11 depletion in U2932 cells 5.11
Nucleoporin-mediated regulation of cell identity genes 5.08
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 5.06
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 5.05
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 5.05
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 5.03
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 5.03
Role of microRNAs in the interaction between Salmonella and the host cell 5.02
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 5.01
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 4.98
Transcriptome of activated human and mouse MAIT cells 4.98
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 4.98
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 4.96
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 4.95
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 4.9
Splicing and epigenetic factors jointly regulate epidermal differentiation 4.9
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 4.85
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 4.85
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 4.81
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 4.8
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 4.73
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 4.69
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 4.69
Identification of renal resident macrophages across species 4.67
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 4.67
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 4.66
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 4.65
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 4.65
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 4.64
Characterization of human ILC2 subsets 4.61
EWSR1 influences alternative splicing through direct and indirect mechanisms 4.6
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 4.6
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 4.6
Region-specific Innate Antiviral Responses of the Human Epididymis 4.55
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 4.54
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 4.52
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 4.48
Gene expression analysis upon mtDNA depletion [RNA-seq] 4.47
Gene expression analysis upon mtDNA depletion 4.47
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 4.44
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 4.44
N6-methyladenine DNA Modification in Glioblastoma 4.44
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 4.37
Genes significantly down or Up-regulated upon RNF219 knockdown 4.37
DRB/GRO-Seq -/+ UV 4.36
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 4.35
Transcriptomes of human monocytes after ex vivo exposure to uric acid 4.35
RNA-seq of MDA-MB-231 cells with TET1 knockout 4.34
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 4.34
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 4.33
LIN28A modulates splicing and gene expression programs in breast cancer cells 4.31
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 4.31
CD95/Fas ligand mRNA is toxic to cells 4.31
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 4.29
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 4.26
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 4.26
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 4.25
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 4.25
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 4.22
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 4.22
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 4.21
Systematic discovery of endogenous human ribonucleoprotein complexes 4.21
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 4.17
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 4.17
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 4.17
MicroRNA-125a-5p overexpression in human macrophages 4.16
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 4.15
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 4.14
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 4.14
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 4.14
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 4.13
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 4.08
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 4.07
RNAseq Analysis in glioblastoma cells treated with Mepazine 4.04
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 4.03
HNRNPM-regulated splicing dependencies in prostate cancer 4.03
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 4.02
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 4.01
LncRNA expression profiling of ischemic stroke patients 3.99
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 3.98
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 3.97
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 3.97
RNA-seq of YB5 cells treated with Proscillaridin A 3.95
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 3.95
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 3.94
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 3.94
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 3.92
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 3.92
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 3.91
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 3.87
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 3.87
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 3.82
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 3.78
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 3.77
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 3.77
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 3.77
ARS2 is a general suppressor of pervasive transcription [RNAseq] 3.77
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 3.76
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 3.76
Transcriptional changes in lymphoma cells induced by LSD1 depletion 3.76
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 3.75
SLIGRL-induced gene expression changes in NHEK cells 3.74
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 3.73
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 3.73
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 3.73
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 3.7
RNA Sequencing of three pairs of gastric cancer 3.69
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 3.68
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 3.67
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 3.64
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 3.61
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 3.6
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 3.54
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 3.53
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 3.53
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 3.53
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 3.51
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 3.51
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 3.51
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 3.49
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 3.49
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 3.48
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 3.48
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 3.48
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 3.48
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 3.47
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 3.43
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 3.43
Capturing the Interactome of Newly Transcribed RNA (RICK) 3.42
Capturing the Interactome of Newly Transcribed RNA 3.42
Small-molecule targeting of brachyury transcription factor addiction in chordoma 3.41
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 3.4
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 3.39
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 3.38
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 3.37
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 3.36
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 3.36
Epigenetic reprogramming of melanoma cells by vitamin C treatment 3.33
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 3.33
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 3.32
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 3.32
RNA sequencing with KSHV infection and enrichment for circular RNAs 3.3
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 3.29
Gene expression in GBM with Cav3.2 inhibition 3.28
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 3.16
Transcriptome landscape of HeLa response upon triamcinolone acetonide 3.16
Transcriptomic analysis of the HOTAIR-regulated genes 3.12
RNA-Seq in neutrophils from Antiphospholipid Syndrome 3.12
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 3.11
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 3.11
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 3.09
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 3.09
RNA-Seq from human ILC transitional populations 3.09
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 3.08
hnRNP C is a key regulator of protein synthesis in mitosis 3.08
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 3.08
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 3.05
UV_24h_GRO-Seq 3.02
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 2.97
SETBP1-WT and SETBP1-G870S epigenetic landscapes 2.97
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 2.94
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 2.89
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 2.86
A novel target of EZH1/2 for treatment of mantle cell lymphoma 2.79
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 2.77
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 2.76
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 2.76
Hypoxic transcriptome of SQ20B human head and neck cancer cells 2.72
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 2.71
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 2.7
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 2.68
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  2.68
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 2.65
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 2.61
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 2.6
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 2.6
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 2.6
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 2.58
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 2.58
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 2.57
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 2.54
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 2.47
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 2.47
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 2.41
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 2.41
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 2.36
Widespread intronic polyadenylation diversifies immune cell transcriptomes 2.34
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 2.32
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 2.31
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 2.3
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 2.3
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 2.3
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 2.29
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 2.29
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 2.26
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 2.2
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 2.19
Microprocessor mediates transcription termination in long noncoding microRNA genes 2.17
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 2.17
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 2.16
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 2.13
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 2.13
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 2.12
Human Treg NaCl stimulation 2.11
Transcriptome analysis revealed impaired cAMP responsiveness in PHF21A-deficient human cells 2.1
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 2.1
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 2.09
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 2.08
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 2.08
Gene expression profile in breast cancer cells 2.05
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 2.05
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 2.04
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 1.97
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 1.97
Solid phase chemistry to covalently and reversibly capture thiolated RNA 1.94
Functional significance of the HIV-1 Tat signature amino acid residues 1.93
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 1.93
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 1.9
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 1.88
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 1.87
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 1.83
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 1.79
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 1.79
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 1.71
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 1.7
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 1.7
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 1.66
Transcriptome analysis of peripheral blood monocytes 1.64
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 1.64
Human Treg IFNg/IL-10 subpopulations 1.59
Transcriptomic analysis of ERR alpha orphan nuclear receptor 1.57
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 1.56
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 1.55
m6A-dependent regulation of messenger RNA stability 1.54
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 1.52
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 1.51
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 1.51
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.51
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 1.46
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.46
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 1.45
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 1.44
Transcriptome analysis of CNS leukemia 1.44
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 1.43
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 1.42
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 1.38
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 1.37
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 1.36
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 1.36
LIN28A Over-expression RNAseq 1.36
Frailty in middle age is associated with race-specific changes to the transcriptome. 1.35
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 1.35
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 1.35
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 1.33
The cohesin release factor WAPL restricts chromatin loop extension. 1.33
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 1.33
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 1.32
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 1.32
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 1.31
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 1.31
The role of CFTR in islet function 1.31
mRNA recovered upon RNF219 IP. [RNA-IP] 1.28
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 1.28
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 1.24
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 1.24
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 1.23
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 1.22
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 1.2
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 1.18
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 1.17
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  1.16
Noncoding regions are the main source of targetable tumor-specific antigens 1.15
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 1.13
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 1.12
Gene expression patterns define the hepatocyte-like cells derived by different strategies 1.12
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 1.1
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 1.08
The circadian transcriptional landscape in primary human mammary epithelial cells 1.08
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 1.05
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 1.04
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region 1.02
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 1.01
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 0.94
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 0.87
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 0.83
Effect of nuclear IL-33 on gene expression 0.83
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 0.81
A transcriptome dataset revealing the molecular features of breast cancer stem cells 0.81
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 0.77
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.69
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.68
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 0.65
Myc activation coordinates gene transcription and protein translation responses 0.63
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.61
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 0.57
Gene expression analysis of human hepatocellular cancers 0.55
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 0.51
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 0.51
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 0.51
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 0.5
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.5
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 0.5
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 0.45
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 0.42
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 0.42
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 0.42
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 0.4
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 0.4
Zika virus infection reprograms global transcription of host cells to allow sustained infection 0.4
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 0.39
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.34
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.34
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.34
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.34
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 0.32
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 0.32
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 0.31
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 0.3
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.27
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 0.26
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 0.26
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.25
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.24
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 0.17
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.16
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.16
Modulation of nonsense-mediated decay by rapamycin 0.15
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 0.14
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.13
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 0.12
K562 polyA RNA-Seq 0.12
Transcriptome-wide modulation of splicing by the exon junction complex 0.07
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 0.05
Aging-associated patterns in the expression of human endogenous retroviruses 0.05
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 0.04
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 0.04
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.04
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.04
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 0.03
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation